Stocks and Investing Stocks and Investing
Fri, October 13, 2023
Thu, October 12, 2023

Oren Livnat Reiterated (VRCA) at Strong Buy and Held Target at $12 on, Oct 12th, 2023


Published on 2024-10-28 06:51:56 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Reiterated "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy and Held Target at $12 on, Oct 12th, 2023.

Oren has made no other calls on VRCA in the last 4 months.



There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Oren's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Oren


  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $10 on, Wednesday, August 23rd, 2023
  • Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $14 on, Tuesday, July 25th, 2023
Contributing Sources